Fine Ark Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Coimbatore, Tamil Nadu, India, established in 2021.
2021 Coimbatore, Tamil Nadu, India Active
Last Updated:
About Fine Ark Pharma Private Limited

Fine Ark Pharma Private Limited, a active private limited company, was established on 21 October 2021 in Coimbatore, Tamil Nadu, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239TZ2021PTC037346. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Kanakalingam Koushik Prabhu (Director), Rupa Ramdas (Director), Rajkanth Roshni (Director). It is based at 3B 4Th Floor, Avinashi Road Nava India, Coimbatore, Tamil Nadu, 641004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TZ2021PTC037346

  • Registration Number

    037346

  • Incorporation Date

    21 October 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Coimbatore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 3 Months
Company report

Fine Ark Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fine Ark Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Fine Ark Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Kanakalingam Koushik Prabhu Director 21 Oct 2021 Current
Rupa Ramdas Director 21 Oct 2021 Current
Rajkanth Roshni Director 21 Oct 2021 Current
Arumugasamy Anbukkili Managing Director 21 Oct 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fine Ark Pharma.

Enhance accessibility to Fine Ark Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Fine Ark Pharma revenue growth over time
Fine Ark Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fine Ark Pharma?

Unlock access to Fine Ark Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Fine Ark Pharma?

Unlock and access historical data on people associated with Fine Ark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fine Ark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fine Ark Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fine Ark Pharma
Recent Activity within the Organization
  • Director Appointment

    Kanakalingam Koushik Prabhu was appointed as a Director was appointed as a Director on 21 Oct 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Director Appointment

    Rupa Ramdas was appointed as a Director was appointed as a Director on 21 Oct 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Director Appointment

    Rajkanth Roshni was appointed as a Director was appointed as a Director on 21 Oct 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Director Appointment

    Arumugasamy Anbukkili was appointed as a Managing Director was appointed as a Managing Director on 21 Oct 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Company Incorporation

    Fine Ark Pharma Private Limited was registered on 21 Oct 2021 with Roc Coimbatore & aged 4 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Fine Ark Pharma Private Limited?

The CIN of Fine Ark Pharma Private Limited is U24239TZ2021PTC037346.

Where is Fine Ark Pharma Private Limited headquartered?

Fine Ark Pharma Private Limited is headquartered at 3B 4Th Floor, Avinashi Road Nava India, Coimbatore, Tamil Nadu, 641004.

When was Fine Ark Pharma Private Limited incorporated?

Fine Ark Pharma Private Limited was incorporated on 21 October 2021.

Who are the current directors of Fine Ark Pharma Private Limited?

The current directors of Fine Ark Pharma Private Limited are

What is the primary industry of Fine Ark Pharma Private Limited?

The primary industry of Fine Ark Pharma Private Limited is Chemicals.

Is Fine Ark Pharma Private Limited a listed company?

Fine Ark Pharma Private Limited is unlisted.

What is the capital structure of Fine Ark Pharma Private Limited?

The authorized capital of Fine Ark Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available